Home  |  Contact

UniProtKB/Swiss-Prot P22033: Variant p.Ile505Thr

Methylmalonyl-CoA mutase, mitochondrial
Gene: MMUT
Variant information

Variant position:  505
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Isoleucine (I) to Threonine (T) at position 505 (I505T, p.Ile505Thr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and hydrophobic (I) to medium size and polar (T)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In MMAM; decreased protein expression; decreased methylmalonyl-CoA mutase activity.
Any additional useful information about the variant.



Sequence information

Variant position:  505
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  750
The length of the canonical sequence.

Location on the sequence:   VIVGVNKYQLEKEDAVEVLA  I DNTSVRNRQIEKLKKIKSSR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VIVGVNKYQLEKEDAVEVLAIDNTSVRNRQIEKLKKIKSSR

Mouse                         VIVGVNKYQLEKEDSVEVLAIDNTSVRKKQIEKLKKIKSSR

Pig                           VIVGVNKYQLEKEESVEVLAIDNTSVRNKQIEKLKKVNPAG

Bovine                        VIVGVNKYQLEKEESVDVLAIDNTSVRNKQIEKLKKVKSSR

Caenorhabditis elegans        VIVGVNKYRLDHEQQVEVLKIDNAKVREEQCAKLNHIRATR

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 33 – 750 Methylmalonyl-CoA mutase, mitochondrial


Literature citations

Structure of the human methylmalonyl-CoA mutase (MUT) locus.
Nham S.U.; Wilkemeyer M.F.; Ledley F.D.;
Genomics 8:710-716(1990)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS HIS-532 AND VAL-671; VARIANT MMAM THR-505;

Eight novel MUT loss-of-function missense mutations in Chinese patients with isolated methylmalonic academia.
Han L.S.; Huang Z.; Han F.; Wang Y.; Gong Z.W.; Gu X.F.;
World J. Pediatr. 13:381-386(2017)
Cited for: VARIANTS MMAM PRO-140; THR-141; VAL-161; GLY-309; THR-505; LYS-514; ARG-597 AND ASP-723; CHARACTERIZATION OF VARIANTS MMAM PRO-140; THR-141; VAL-161; GLY-309; THR-505; LYS-514; ARG-597 AND ASP-723; FUNCTION; CATALYTIC ACTIVITY;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.